Determination of RNA structural diversity and its role in HIV-1 RNA splicing.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
06 2020
Historique:
received: 12 05 2019
accepted: 04 03 2020
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 22 9 2020
Statut: ppublish

Résumé

Human immunodeficiency virus 1 (HIV-1) is a retrovirus with a ten-kilobase single-stranded RNA genome. HIV-1 must express all of its gene products from a single primary transcript, which undergoes alternative splicing to produce diverse protein products that include structural proteins and regulatory factors

Identifiants

pubmed: 32555469
doi: 10.1038/s41586-020-2253-5
pii: 10.1038/s41586-020-2253-5
pmc: PMC7310298
mid: NIHMS1572068
doi:

Substances chimiques

RNA Splice Sites 0
RNA, Viral 0
Sulfuric Acid Esters 0
dimethyl sulfate JW5CW40Z50

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

438-442

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI050470
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI134365
Pays : United States
Organisme : NIAID NIH HHS
ID : U54 AI150470
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Purcell, D. F. & Martin, M. A. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67, 6365–6378 (1993).
doi: 10.1128/jvi.67.11.6365-6378.1993
Ocwieja, K. E. et al. Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing. Nucleic Acids Res. 40, 10345–10355 (2012).
doi: 10.1093/nar/gks753
Takata, M. A. et al. Global synonymous mutagenesis identifies cis-acting RNA elements that regulate HIV-1 splicing and replication. PLoS Pathog. 14, e1006824 (2018).
doi: 10.1371/journal.ppat.1006824
Watts, J. M. et al. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460, 711–716 (2009).
doi: 10.1038/nature08237
Sherpa, C., Rausch, J. W., Le Grice, S. F., Hammarskjold, M. L. & Rekosh, D. The HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication. Nucleic Acids Res. 43, 4676–4686 (2015).
doi: 10.1093/nar/gkv313
Warf, M. B. & Berglund, J. A. Role of RNA structure in regulating pre-mRNA splicing. Trends Biochem. Sci. 35, 169–178 (2010).
doi: 10.1016/j.tibs.2009.10.004
Shepard, P. J. & Hertel, K. J. Conserved RNA secondary structures promote alternative splicing. RNA 14, 1463–1469 (2008).
doi: 10.1261/rna.1069408
Singh, N. N., Lee, B. M. & Singh, R. N. Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions. Ann. NY Acad. Sci. 1341, 176–187 (2015).
doi: 10.1111/nyas.12727
Huthoff, H. & Berkhout, B. Two alternating structures of the HIV-1 leader RNA. RNA 7, 143–157 (2001).
doi: 10.1017/S1355838201001881
Abbink, T. E., Ooms, M., Haasnoot, P. C. & Berkhout, B. The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation. Biochemistry 44, 9058–9066 (2005).
doi: 10.1021/bi0502588
Zubradt, M. et al. DMS-MaPseq for genome-wide or targeted RNA structure probing in vivo. Nat. Methods 14, 75–82 (2017).
doi: 10.1038/nmeth.4057
Bishop, C. M. Pattern Recognition and Machine Learning (Springer, 2006).
Reuter, J. S. & Mathews, D. H. RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinformatics 11, 129 (2010).
doi: 10.1186/1471-2105-11-129
Spasic, A., Assmann, S. M., Bevilacqua, P. C. & Mathews, D. H. Modeling RNA secondary structure folding ensembles using SHAPE mapping data. Nucleic Acids Res. 46, 314–323 (2018).
doi: 10.1093/nar/gkx1057
Homan, P. J. et al. Single-molecule correlated chemical probing of RNA. Proc. Natl Acad. Sci. USA 111, 13858–13863 (2014).
doi: 10.1073/pnas.1407306111
Sengupta, A., Rice, G. M. & Weeks, K. M. Single-molecule correlated chemical probing reveals large-scale structural communication in the ribosome and the mechanism of the antibiotic spectinomycin in living cells. PLoS Biol. 17, e3000393 (2019).
doi: 10.1371/journal.pbio.3000393
Ding, Y. & Lawrence, C. E. A statistical sampling algorithm for RNA secondary structure prediction. Nucleic Acids Res. 31, 7280–7301 (2003).
doi: 10.1093/nar/gkg938
Halvorsen, M., Martin, J. S., Broadaway, S. & Laederach, A. Disease-associated mutations that alter the RNA structural ensemble. PLoS Genet. 6, e1001074 (2010).
doi: 10.1371/journal.pgen.1001074
Wan, Y. et al. Landscape and variation of RNA secondary structure across the human transcriptome. Nature 505, 706–709 (2014).
doi: 10.1038/nature12946
Tian, S., Kladwang, W. & Das, R. Allosteric mechanism of the V. vulnificus adenine riboswitch resolved by four-dimensional chemical mapping. eLife 7, e29602 (2018).
doi: 10.7554/eLife.29602
Lemay, J. F. et al. Comparative study between transcriptionally- and translationally-acting adenine riboswitches reveals key differences in riboswitch regulatory mechanisms. PLoS Genet. 7, e1001278 (2011).
doi: 10.1371/journal.pgen.1001278
Zaug, A. J. & Cech, T. R. Analysis of the structure of Tetrahymena nuclear RNAs in vivo: telomerase RNA, the self-splicing rRNA intron, and U2 snRNA. RNA 1, 363–374 (1995).
pubmed: 7493315 pmcid: 1482408
Emery, A., Zhou, S., Pollom, E. & Swanstrom, R. Characterizing HIV-1 splicing by using next-generation sequencing. J. Virol. 91, e02515-16 (2017).
doi: 10.1128/JVI.02515-16
Schwarz, G. Estimating the dimension of a model. Ann. Stat. 6, 461–464 (1978).
doi: 10.1214/aos/1176344136
Rouskin, S., Zubradt, M., Washietl, S., Kellis, M. & Weissman, J. S. Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo. Nature 505, 701–705 (2014).
doi: 10.1038/nature12894
Liu, Y. et al. The roles of five conserved lentiviral RNA structures in HIV-1 replication. Virology 514, 1–8 (2018).
doi: 10.1016/j.virol.2017.10.020
Kondo, Y., Oubridge, C., van Roon, A. M. & Nagai, K. Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5′ splice site recognition. eLife 4, e04986 (2015).
Cornilescu, G. et al. Structural analysis of multi-helical RNAs by NMR-SAXS/WAXS: application to the U4/U6 di-snRNA. J. Mol. Biol. 428 (5 Pt A), 777–789 (2016).
doi: 10.1016/j.jmb.2015.11.026
Xiong, H. Y. et al. The human splicing code reveals new insights into the genetic determinants of disease. Science 347, 1254806 (2015).
doi: 10.1126/science.1254806
Faustino, N. A. & Cooper, T. A. Pre-mRNA splicing and human disease. Genes Dev. 17, 419–437 (2003).
doi: 10.1101/gad.1048803
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
doi: 10.1038/nmeth.1923
Darty, K., Denise, A. & Ponty, Y. VARNA: interactive drawing and editing of the RNA secondary structure. Bioinformatics 25, 1974–1975 (2009).
doi: 10.1093/bioinformatics/btp250
Adachi, A. et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284–291 (1986).
doi: 10.1128/jvi.59.2.284-291.1986
Lahm, H. W. & Stein, S. Characterization of recombinant human interleukin-2 with micromethods. J. Chromatogr. A 326, 357–361 (1985).
doi: 10.1016/S0021-9673(01)87461-6

Auteurs

Phillip J Tomezsko (PJ)

Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
Program in Virology, Harvard Medical School, Boston, MA, USA.
Brigham and Women's Hospital, Boston, MA, USA.

Vincent D A Corbin (VDA)

Bioinformatics Division, Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.

Paromita Gupta (P)

Whitehead Institute for Biomedical Research, Cambridge, MA, USA.

Harish Swaminathan (H)

Whitehead Institute for Biomedical Research, Cambridge, MA, USA.

Margalit Glasgow (M)

Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
Massachusetts Institute of Technology, Cambridge, MA, USA.

Sitara Persad (S)

Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
Massachusetts Institute of Technology, Cambridge, MA, USA.

Matthew D Edwards (MD)

Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA.

Lachlan Mcintosh (L)

Bioinformatics Division, Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Department of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia.

Anthony T Papenfuss (AT)

Bioinformatics Division, Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Department of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Ann Emery (A)

Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Ronald Swanstrom (R)

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Trinity Zang (T)

Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA.

Tammy C T Lan (TCT)

Whitehead Institute for Biomedical Research, Cambridge, MA, USA.

Paul Bieniasz (P)

Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA.
Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA.

Daniel R Kuritzkes (DR)

Brigham and Women's Hospital, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Athe Tsibris (A)

Brigham and Women's Hospital, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Silvi Rouskin (S)

Whitehead Institute for Biomedical Research, Cambridge, MA, USA. srouskin@wi.mit.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH